Osteopenia:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Osteopenia Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Osteopenia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Osteopenia 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Osteopenia Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Amgen Inc. 32
Clinical Trial Overview of Amgen Inc. 32
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
F. Hoffmann-La Roche Ltd. 34
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34
Nestle SA 35
Clinical Trial Overview of Nestle SA 35
Warner Chilcott Plc 36
Clinical Trial Overview of Warner Chilcott Plc 36
Integrative Health Technologies, Inc. 37
Clinical Trial Overview of Integrative Health Technologies, Inc. 37
Solvay Pharma Inc. 38
Clinical Trial Overview of Solvay Pharma Inc. 38
Duramed Research Inc. 39
Clinical Trial Overview of Duramed Research Inc. 39
Eidgenossische Technische Hochschule Zurich 40
Clinical Trial Overview of Eidgenossische Technische Hochschule Zurich 40
POM Wonderful, LLC. 41
Clinical Trial Overview of POM Wonderful, LLC. 41
Sanos Bioscience A/S 42
Clinical Trial Overview of Sanos Bioscience A/S 42
BioActor 43
Clinical Trial Overview of BioActor 43
Deltanoid Pharmaceuticals Inc. 44
Clinical Trial Overview of Deltanoid Pharmaceuticals Inc. 44
Emisphere Technologies, Inc. 45
Clinical Trial Overview of Emisphere Technologies, Inc. 45
Bayer AG 46
Clinical Trial Overview of Bayer AG 46
Azelon Pharmaceuticals Inc. 47
Clinical Trial Overview of Azelon Pharmaceuticals Inc. 47
Pfizer Inc. 48
Clinical Trial Overview of Pfizer Inc. 48
Marina Biotech, Inc. 49
Clinical Trial Overview of Marina Biotech, Inc. 49
GlaxoSmithKline plc 50
Clinical Trial Overview of GlaxoSmithKline plc 50
Sanofi 51
Clinical Trial Overview of Sanofi 51
Clinical Trial Overview of Top Institutes / Government 52
Massachusetts General Hospital 52
Clinical Trial Overview of Massachusetts General Hospital 52
National Institute of Arthritis and Musculoskeletal and Skin Diseases 53
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 53
University of Wisconsin Madison 54
Clinical Trial Overview of University of Wisconsin Madison 54
King’s College London 55
Clinical Trial Overview of King’s College London 55
University of Messina 56
Clinical Trial Overview of University of Messina 56
Duquesne University 57
Clinical Trial Overview of Duquesne University 57
University of California, San Francisco 58
Clinical Trial Overview of University of California, San Francisco 58
Emory University 59
Clinical Trial Overview of Emory University 59
Hospices Civils de Lyon 60
Clinical Trial Overview of Hospices Civils de Lyon 60
National Taiwan University Hospital 61
Clinical Trial Overview of National Taiwan University Hospital 61
University of Sao Paulo 62
Clinical Trial Overview of University of Sao Paulo 62
Aarhus University 63
Clinical Trial Overview of Aarhus University 63
The National Institute of Allergy and Infectious Diseases 64
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 64
Mayo Clinic 65
Clinical Trial Overview of Mayo Clinic 65
University of Missouri 66
Clinical Trial Overview of University of Missouri 66
Medical University of Vienna 67
Clinical Trial Overview of Medical University of Vienna 67
U.S. Department of Veterans Affairs 68
Clinical Trial Overview of U.S. Department of Veterans Affairs 68
Queen’s University 69
Clinical Trial Overview of Queen’s University 69
University of Pennsylvania 70
Clinical Trial Overview of University of Pennsylvania 70
National Center for Research Resources 71
Clinical Trial Overview of National Center for Research Resources 71
Five Key Clinical Profiles 72
Appendix 164
Abbreviations 164
Definitions 164
Research Methodology 165
Secondary Research 165
About GlobalData 166
Contact Us 166
Disclaimer 166
Source 167


【レポート販売概要】

■ タイトル:Osteopenia:グローバル臨床試験レビューH2, 2013
■ 英文:Osteopenia Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月25日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162071
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。